Abstract
Postpartum hemorrhage (PPH) is an underestimated problem in labor and delivery units and remains a leading cause of maternal morbidity and mortality worldwide. Managing PPH starts with immediate recognition and intervention. Goal-directed massive transfusion protocol can be achieved by properly monitoring the maternal coagulation profile during severe obstetric hemorrhage. Conventional coagulation tests (prothrombin time, activated partial thromboplastin time, international normalized ratio, fibrinogen analysis, platelet count) have long turnaround times (occasionally >60 min and provide little information about the in vivo condition of hemostasis) compared to viscoelastic tests (VETs) (available results within 10–30 min). The outcome in actively hemorrhaging patients can be optimized by VETs, including thromboelastography (TEG), rotational thromboelastometry and Sonoclot, providing more individualized blood component therapy compared to traditional 1:1:1 ‘damage control resuscitation’ ratios of blood transfusion strategy. The main limitations of the efficacy of VETs include, but are not limited to, the lack of validation, not having well-established reference ranges for each patient group, results affected by fluid resuscitation regimes and consistent operator proficiency. Although there is limited data with the use of VETs in obstetric patients, the value of VETs is supported by guidelines with increasing evidence. This article will demonstrate two obstetric cases to evaluate the reliability of the TEG in the management of postpartum coagulopathies. The lesson we took from our two cases is presented.
Acknowledgments
The patients who are the subject of this case report were identified among women who attended UF Health Shands Hospital in Gainesville, FL, USA. The authors would like to thank Bernie Amaro for his editorial support. Mr. Amaro is a research assistant in the Department of Obstetrics and Gynecology at the University of Florida.
Ethical approval: The research related to human use has complied with all the relevant national regulations, institutional policies and has been conducted in accordance with the tenets of the Helsinki Declaration, and it has been approved by the authors’ Institutional Review Board or equivalent committee.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
[1] Callaghan WM, Kuklina EV, Berg CJ. Trends in postpartum hemorrhage: United States, 1994–2006. Am J Obstet Gynecol. 2010;202:353. e1–6.10.1097/01.aoa.0000397145.24137.f5Search in Google Scholar
[2] Karlsson O, Sporrong T, Hillarp A, Jeppsson A, Hellgren M. Prospective longitudinal study of thromboelastography and standard hemostatic laboratory tests in healthy women during normal pregnancy. Anesth Analg. 2012;115:890–8.10.1213/ANE.0b013e3182652a33Search in Google Scholar PubMed
[3] Butwick AJ. Postpartum hemorrhage and low fibrinogen levels: the past, present and future. Int J Obstet Anesth. 2013;22:87–91.10.1016/j.ijoa.2013.01.002Search in Google Scholar PubMed
[4] Charbit B, Mandelbrot L, Samain E, Baron G, Haddaoui B, Keita H, et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost. 2007;5:266–73.10.1111/j.1538-7836.2007.02297.xSearch in Google Scholar PubMed
[5] Mallaiah S, Barclay P, Harrod I, Chevannes C, Bhalla A. Introduction of an algorithm for ROTEM-guided fibrinogen concentrate administration in major obstetric haemorrhage. Anaesthesia. 2015;70:166–75.10.1111/anae.12859Search in Google Scholar PubMed
[6] Kaufner L, Henkelmann A, von Heymann C, Feldheiser A, Mickley L, Niepraschk-von Dollen K, et al. Can prepartum thromboelastometry-derived parameters and fibrinogen levels really predict postpartum hemorrhage? J Perinat Med. 2017;45:427–35.10.1515/jpm-2016-0009Search in Google Scholar PubMed
[7] Wikkelso AJ, Edwards HM, Afshari A, Stensballe J, Langhoff-Roos J, Albrechtsen C, et al. Pre-emptive treatment with fibrinogen concentrate for postpartum haemorrhage: randomized controlled trial. Br J Anaesth. 2015;114:623–33.10.1093/bja/aeu444Search in Google Scholar PubMed
[8] Ducloy-Bouthors AS, Mignon A, Huissoud C, Grouin JM, Mercier FJ. Fibrinogen concentrate as a treatment for postpartum haemorrhage-induced coagulopathy: a study protocol for a randomised multicentre controlled trial. The fibrinogen in haemorrhage of DELivery (FIDEL) trial. Anaesth Crit Care Pain Med. 2016;35:293–8.10.1016/j.accpm.2015.10.011Search in Google Scholar PubMed
[9] Smith R, Campbell-Owen T, Maybury H, Pavord S, Waugh J. Thromboelastography and peripartum coagulation profiles associated with caesarean section delivery. Obstet Med. 2009;2:111–5.10.1258/om.2009.080018Search in Google Scholar PubMed PubMed Central
[10] Sharma SK, Phillip J, Whitten CW, Padakandla WB, Landers DF. Assessment of changes in coagulation in parturients with preeclampsia using thromboelastography. Anesthesiology. 1999;90:385–90.10.1097/00000542-199902000-00009Search in Google Scholar PubMed
[11] Handa AC, Pasi KJ, Perry DJ. Thromboelastography: an effective screening test for prothrombotic states. Phlebology. 1997;12:159–60.Search in Google Scholar
[12] Liu EH, Shailaja S, Koh SC, Lee TL. An assessment of the effects on coagulation of midtrimester and final-trimester amniotic fluid on whole blood by Thrombelastograph analysis. Anesth Analg. 2000;90:333–6.10.1213/00000539-200002000-00018Search in Google Scholar
[13] American Society of Anesthesiologists Task Force on Perioperative Blood Management. Practice guidelines for perioperative blood management: an updated report by the American Society of Anesthesiologists. Task Force on Perioperative Blood Management. Anesthesiology. 2015;122:241–7510.1097/ALN.0000000000000463Search in Google Scholar PubMed
[14] Curry NS, Davenport R, Pavord S, Mallett SV, Kitchen D, Klein AA, et al. The use of viscoelastic haemostatic assays in the management of major bleeding: a British Society for Haematology Guideline. Br J Haematol. 2018;182:789–806 .10.1111/bjh.15524Search in Google Scholar PubMed
Supplementary Material
The online version of this article offers supplementary material (DOI: https://doi.org/10.1515/crpm-2019-0058).
© 2020 Walter de Gruyter GmbH, Berlin/Boston
